Bucillamine Study of Holding Remission After Infliximab Dose-off

NCT00716248 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: bucillamine
DRUG: methotrexate

Sponsor

Saitama Medical University

Collaborators

[object Object]